Revisiting Estrogen for the Treatment of Endocrine-Resistant Breast Cancer: Novel Therapeutic Approaches

SIMPLE SUMMARY: Estrogen is known to drive the growth of estrogen-receptor-positive breast cancers, the most common breast cancer subtype. Drugs that target the estrogen receptor by blocking estrogen signaling are the mainstay of treatment. These drugs include tamoxifen, aromatase inhibitors and sel...

Descripción completa

Detalles Bibliográficos
Autores principales: Shete, Nivida, Calabrese, Jordan, Tonetti, Debra A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377916/
https://www.ncbi.nlm.nih.gov/pubmed/37509308
http://dx.doi.org/10.3390/cancers15143647

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377916/
https://www.ncbi.nlm.nih.gov/pubmed/37509308
http://dx.doi.org/10.3390/cancers15143647

Ejemplares similares